Evidence map›Paper›PMID 40445928›Full record

ArticlePloS one2025

The influence of the Big Five inventory on quality of life in people with Parkinson's disease aged 50 and above: A Longitudinal Analysis from the Survey of Health, Aging and Retirement in Europe (SHARE).

Sarah Mendorf, Konstantin G Heimrich, Hannah M Mühlhammer, Aline Schönenberg, Tino Prell

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sarah MendorfDepartment of Neurology, University Hospital Jena, Jena, Germany.ORCID 0000-0002-1297-6014
Konstantin G HeimrichDepartment of Neurology, University Hospital Jena, Jena, Germany.
Hannah M MühlhammerDepartment of Neurology, University Hospital Jena, Jena, Germany.ORCID 0000-0003-2211-9865
Aline SchönenbergDepartment of Geriatrics, University Hospital Halle, Halle, Germany.
Tino PrellDepartment of Neurology, University Hospital Jena, Jena, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParkinson's disease (PD) significantly reduces quality of life (QoL), particularly due to its complex interplay of motor and nonmotor symptoms. While personality traits influence QoL in chronic diseases, their longitudinal effects in people with PD (PwPD) remain underexplored. This study evaluates the longitudinal predictive influence of neuroticism, conscientiousness, and openness on QoL in PwPD over two waves of the Survey of Health, Aging, and Retirement in Europe (SHARE).

methodsThis study utilized longitudinal data from 100 PwPD participants in waves 7 and 8 of the Survey of Health, Aging, and Retirement in Europe (SHARE). QoL was assessed using the CASP-12 scale, while personality traits were measured with the Big Five Inventory (BFI-10). Linear regressions and generalized estimating equations (GEE) were used to examine cross-sectional and longitudinal associations between personality traits and QoL, controlling for sociodemographic, psychosocial, and health-related variables.

resultsNeuroticism was consistently associated with lower QoL across all analyses. Cross-sectional results showed neuroticism as the strongest predictor of QoL decline in wave 7 (beta = -0.33, p < 0.001), and longitudinal GEE analyses confirmed its predictive effect (beta = -0.03, p = 0.007). Conscientiousness and openness showed limited and inconsistent associations with QoL. Beyond personality traits, depressive symptoms and mobility limitations were found to substantially impact QoL, influencing the effects of neuroticism.

conclusionsNeuroticism plays a pivotal role in predicting QoL decline in PwPD, highlighting its utility as a target for psychological interventions aimed at emotional regulation and resilience building. While depressive symptoms and mobility limitations also contribute, integrating personality assessments into care strategies may improve outcomes. These findings advocate for a multidimensional approach to managing PD that addresses both clinical and psychological factors.

Indexed as

AgingParkinson DiseaseQuality of LifeAgedAged, 80 and overCross-Sectional StudiesEuropeFemaleHealth SurveysHumansLongitudinal StudiesMaleMiddle AgedNeuroticismPersonalityPersonality Inventory

Identifiers

PMID40445928
PMCPMC12124528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.